ELTROMBOPAG

ELTROMBOPAG was reported 23242 times

ELTROMBOPAG is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MYELODYSPLASTIC SYNDROME WITH RINGED SIDEROBLASTS 4 0.4444
1 LUNG DISEASE INFECTIVE EXACERBATION 10 0.3704
2 SERUM COLOUR ABNORMAL 7 0.3500
3 SPLENOSIS 4 0.2353
4 HEPATITIS G 6 0.2143
5 PANCREATIC PSEUDOANEURYSM 4 0.2105
6 AUTOIMMUNE PANCYTOPENIA 12 0.1319
7 MUCOCUTANEOUS HAEMORRHAGE 17 0.1141
8 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA 44 0.0938
9 PLATELET DESTRUCTION INCREASED 4 0.0889
10 TOOTH DISLOCATION 5 0.0877
11 ACQUIRED AMEGAKARYOCYTIC THROMBOCYTOPENIA 4 0.0833
12 EVANS SYNDROME 31 0.0629
13 BONE MARROW RETICULIN FIBROSIS 16 0.0620
14 MEGAKARYOCYTES ABNORMAL 7 0.0619
15 IMMUNE THROMBOCYTOPENIA 266 0.0580
16 ORAL BLOOD BLISTER 11 0.0550
17 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS 5 0.0538
18 STENOTROPHOMONAS BACTERAEMIA 4 0.0526
19 LEUKOERYTHROBLASTOSIS 5 0.0500
20 MEGAKARYOCYTES INCREASED 6 0.0484
21 CLONAL EVOLUTION 5 0.0481
22 MYELOID MATURATION ARREST 4 0.0449
23 CALCINEURIN INHIBITOR INDUCED PAIN SYNDROME 4 0.0435
24 PLATELET COUNT ABNORMAL 258 0.0426
25 RETICULOCYTOSIS 8 0.0377
26 BONE MARROW MYELOGRAM ABNORMAL 6 0.0345
27 PLATELET COUNT INCREASED 423 0.0324
28 CEREBRAL VENOUS SINUS THROMBOSIS 26 0.0308
29 TRANSPLANT DYSFUNCTION 54 0.0302
30 PARVOVIRUS INFECTION 12 0.0297
31 APLASTIC ANAEMIA 152 0.0291
32 BRONCHIOLITIS OBLITERANS SYNDROME 5 0.0286
33 MYELOFIBROSIS 81 0.0268
34 PETECHIAE 262 0.0251
35 PLATELET DISORDER 63 0.0250
36 BOREDOM 8 0.0236
37 SUBCAPSULAR RENAL HAEMATOMA 5 0.0236
38 LABELLED DRUG-FOOD INTERACTION ISSUE 4 0.0235
39 TUMOUR THROMBOSIS 5 0.0219
40 ANGINA BULLOSA HAEMORRHAGICA 5 0.0216
41 MEAN PLATELET VOLUME INCREASED 13 0.0215
42 OESOPHAGEAL ADENOCARCINOMA 10 0.0210
43 CYSTITIS VIRAL 8 0.0209
44 HYPERFERRITINAEMIA 9 0.0209
45 MARROW HYPERPLASIA 14 0.0205
46 FUNGAL ENDOCARDITIS 6 0.0199
47 ANTIPHOSPHOLIPID SYNDROME 32 0.0199
48 THROMBOCYTOPENIA NEONATAL 8 0.0190
49 DISCOURAGEMENT 43 0.0184
50 MUCOSAL HAEMORRHAGE 20 0.0172
51 THROMBOCYTOSIS 63 0.0172
52 PARVOVIRUS B19 INFECTION 15 0.0168
53 PLATELET COUNT DECREASED 1759 0.0165
54 EYE INFECTION FUNGAL 6 0.0155
55 BIOPSY BONE MARROW ABNORMAL 7 0.0154
56 HAEMOSIDEROSIS 4 0.0149
57 CEREBRAL VENOUS THROMBOSIS 27 0.0149
58 IRON OVERLOAD 16 0.0148
59 HEAD BANGING 8 0.0140
60 SUPERIOR SAGITTAL SINUS THROMBOSIS 11 0.0138
61 HEPATIC ARTERY THROMBOSIS 4 0.0137
62 T-LYMPHOCYTE COUNT DECREASED 9 0.0132
63 ERYTHROPOIESIS ABNORMAL 4 0.0131
64 PULMONARY ARTERY THROMBOSIS 10 0.0130
65 PORTAL VEIN THROMBOSIS 42 0.0130
66 HAEMORRHAGIC DISORDER 14 0.0129
67 PRODUCT SUPPLY ISSUE 91 0.0127
68 HAEMOPERITONEUM 10 0.0125
69 ECTHYMA 5 0.0125
70 GINGIVAL BLEEDING 167 0.0122
71 ANTIPHOSPHOLIPID ANTIBODIES POSITIVE 7 0.0121
72 CYTOMEGALOVIRUS INFECTION REACTIVATION 53 0.0120
73 GINGIVAL HYPERTROPHY 18 0.0119
74 RETICULOCYTE COUNT INCREASED 9 0.0111
75 PNEUMOCYSTIS JIROVECII INFECTION 13 0.0109
76 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 15 0.0106
77 HEPATIC INFARCTION 4 0.0106
78 IMMUNE THROMBOCYTOPENIC PURPURA 30 0.0106
79 MOUTH HAEMORRHAGE 74 0.0101
80 HYPERCREATININAEMIA 5 0.0099
81 ABDOMINAL INJURY 5 0.0096
82 GRAFT VERSUS HOST DISEASE IN SKIN 21 0.0095
83 RETICULOCYTE COUNT DECREASED 4 0.0093
84 BODY FAT DISORDER 5 0.0092
85 ACUTE GRAFT VERSUS HOST DISEASE 42 0.0092
86 SPLENIC INFARCTION 16 0.0092
87 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 12 0.0091
88 CHRONIC MYELOMONOCYTIC LEUKAEMIA 6 0.0091
89 MESENTERIC VEIN THROMBOSIS 9 0.0090
90 CUSHINGOID 29 0.0090
91 ABSCESS ORAL 12 0.0087
92 SERUM SICKNESS 24 0.0086
93 GASTRITIS BACTERIAL 4 0.0086
94 CEREBRAL TOXOPLASMOSIS 8 0.0086
95 HAEMORRHAGIC DIATHESIS 30 0.0084
96 BLOOD BILIRUBIN UNCONJUGATED INCREASED 6 0.0083
97 BODY HEIGHT INCREASED 4 0.0082
98 STENOTROPHOMONAS INFECTION 11 0.0081
99 HYPOFIBRINOGENAEMIA 8 0.0081
100 LYMPHOCYTIC INFILTRATION 8 0.0079
101 HEPATIC INFECTION 10 0.0078
102 FOCAL NODULAR HYPERPLASIA 4 0.0077
103 METAPNEUMOVIRUS INFECTION 6 0.0077
104 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 7 0.0076
105 OVARIAN DISORDER 7 0.0074
106 RENAL VEIN THROMBOSIS 5 0.0074
107 ECCHYMOSIS 50 0.0073
108 MILK ALLERGY 4 0.0072
109 ADRENAL HAEMORRHAGE 4 0.0072
110 SUPERFICIAL VEIN THROMBOSIS 6 0.0071
111 PURPURA 62 0.0070
112 HAEMATOMA INFECTION 4 0.0069
113 CHRONIC GRAFT VERSUS HOST DISEASE 25 0.0069
114 THERAPY NON-RESPONDER 301 0.0067
115 TOXOPLASMOSIS 7 0.0065
116 RED BLOOD CELL ABNORMALITY 6 0.0062
117 ADENOVIRUS INFECTION 18 0.0062
118 CYTOGENETIC ABNORMALITY 7 0.0062
119 PNEUMONIA NECROTISING 4 0.0062
120 SLEEP DEFICIT 13 0.0061
121 DENGUE FEVER 14 0.0061
122 OESOPHAGEAL HAEMORRHAGE 8 0.0060
123 MYELOPROLIFERATIVE NEOPLASM 4 0.0060
124 EMBOLIC CEREBRAL INFARCTION 4 0.0060
125 BRAIN HYPOXIA 6 0.0060
126 INTERMENSTRUAL BLEEDING 33 0.0059
127 GASTRIC PH DECREASED 6 0.0059
128 AUTOIMMUNE HAEMOLYTIC ANAEMIA 20 0.0058
129 CYTOGENETIC ANALYSIS ABNORMAL 6 0.0057
130 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 15 0.0056
131 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 12 0.0056
132 BK VIRUS INFECTION 19 0.0056
133 INTRACRANIAL VENOUS SINUS THROMBOSIS 6 0.0056
134 GRAFT VERSUS HOST DISEASE IN LIVER 4 0.0056
135 GRAFT VERSUS HOST DISEASE 40 0.0056
136 HEAVY MENSTRUAL BLEEDING 50 0.0056
137 CEREBRAL VASOCONSTRICTION 4 0.0054
138 HAEMOCHROMATOSIS 5 0.0054
139 MYELODYSPLASTIC SYNDROME 77 0.0053
140 ATRIAL THROMBOSIS 11 0.0053
141 NEUTROPHIL COUNT ABNORMAL 15 0.0053
142 TRANSPLANT FAILURE 13 0.0053
143 BRAIN STEM HAEMORRHAGE 5 0.0053
144 JAUNDICE NEONATAL 10 0.0053
145 HYPERCOAGULATION 10 0.0052
146 SPLENECTOMY 6 0.0052
147 PNEUMONIA FUNGAL 20 0.0051
148 DYSPLASIA 6 0.0050
149 THERAPY PARTIAL RESPONDER 77 0.0049
150 MEAN CELL HAEMOGLOBIN DECREASED 9 0.0049
151 CYTOPENIA 60 0.0049
152 VENOOCCLUSIVE LIVER DISEASE 24 0.0049
153 GLOMERULAR FILTRATION RATE INCREASED 4 0.0048
154 ACUTE MYELOID LEUKAEMIA 75 0.0048
155 DECREASED IMMUNE RESPONSIVENESS 47 0.0048
156 BLOOD BILIRUBIN ABNORMAL 6 0.0047
157 LAZINESS 8 0.0047
158 MEAN CELL VOLUME INCREASED 12 0.0047
159 STEROID DIABETES 7 0.0047
160 STRESS URINARY INCONTINENCE 5 0.0046
161 GASTROINTESTINAL OEDEMA 8 0.0045
162 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 8 0.0045
163 FEELING OF DESPAIR 21 0.0045
164 CONJUNCTIVAL HAEMORRHAGE 17 0.0044
165 MONOCYTE COUNT INCREASED 16 0.0044
166 ACUTE LEUKAEMIA 7 0.0043
167 AORTIC THROMBOSIS 5 0.0043
168 BONE MARROW DISORDER 13 0.0043
169 THERAPEUTIC RESPONSE DELAYED 12 0.0043
170 HYPOPROTEINAEMIA 8 0.0042
171 KLEBSIELLA BACTERAEMIA 4 0.0042
172 SERUM FERRITIN INCREASED 22 0.0042
173 EYE COLOUR CHANGE 4 0.0039
174 MONOPARESIS 7 0.0039
175 BONE MARROW FAILURE 78 0.0038
176 CYTOMEGALOVIRUS VIRAEMIA 17 0.0038
177 BLAST CELL COUNT INCREASED 4 0.0038
178 APLASIA PURE RED CELL 13 0.0038
179 THROMBOCYTOPENIA 412 0.0037
180 HAEMOLYTIC ANAEMIA 33 0.0037
181 STREPTOCOCCAL BACTERAEMIA 4 0.0037
182 CORNEAL OPACITY 5 0.0037
183 PRODUCT AVAILABILITY ISSUE 83 0.0036
184 ARTERIAL THROMBOSIS 7 0.0036
185 EPSTEIN-BARR VIRAEMIA 4 0.0036
186 GASTRIC DILATATION 6 0.0036
187 VENOOCCLUSIVE DISEASE 9 0.0036
188 FIBROSIS 11 0.0036
189 APLASIA 7 0.0036
190 CONCOMITANT DISEASE AGGRAVATED 22 0.0036
191 GENE MUTATION 7 0.0035
192 BLOOD BLISTER 11 0.0035
193 HYPERBILIRUBINAEMIA 36 0.0035
194 SERUM FERRITIN DECREASED 6 0.0035
195 CORONARY ARTERY THROMBOSIS 7 0.0035
196 BILIRUBIN CONJUGATED INCREASED 8 0.0034
197 GINGIVAL SWELLING 15 0.0034
198 VENOUS THROMBOSIS LIMB 7 0.0034
199 PARAPARESIS 6 0.0034
200 HAEMOGLOBIN DECREASED 345 0.0034
201 GASTROINTESTINAL WALL THICKENING 5 0.0033
202 SPLENOMEGALY 39 0.0033
203 DISEASE RECURRENCE 156 0.0033
204 RED BLOOD CELL COUNT INCREASED 9 0.0033
205 EMBOLISM 27 0.0032
206 STAPHYLOCOCCAL SEPSIS 16 0.0032
207 ASPERGILLUS INFECTION 21 0.0032
208 CYTOMEGALOVIRUS INFECTION 53 0.0032
209 CEREBRAL THROMBOSIS 9 0.0032
210 PNEUMATOSIS INTESTINALIS 9 0.0032
211 OSTEOPOROTIC FRACTURE 6 0.0031
212 CONTUSION 298 0.0031
213 THROMBOTIC MICROANGIOPATHY 30 0.0031
214 HAEMORRHAGE INTRACRANIAL 46 0.0031
215 LYMPHOCYTE COUNT INCREASED 10 0.0031
216 VENOUS THROMBOSIS 12 0.0031
217 HAEMATOMA 79 0.0030
218 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 5 0.0030
219 YELLOW SKIN 14 0.0030
220 HIV INFECTION 9 0.0030
221 HAEMOGLOBIN ABNORMAL 19 0.0030
222 VASCULAR STENT THROMBOSIS 6 0.0029
223 EPISTAXIS 217 0.0029
224 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 8 0.0029
225 HAEMOGLOBIN INCREASED 13 0.0028
226 PERIPHERAL ARTERY THROMBOSIS 4 0.0028
227 HAEMORRHAGE 297 0.0028
228 RETINAL VEIN OCCLUSION 8 0.0028
229 RETINAL ARTERY OCCLUSION 7 0.0028
230 ESCHERICHIA SEPSIS 8 0.0028
231 VENOUS OCCLUSION 5 0.0027
232 BILIARY COLIC 8 0.0027
233 NOCARDIOSIS 7 0.0027
234 AUTOIMMUNE HEPATITIS 19 0.0027
235 NORMOCYTIC ANAEMIA 4 0.0027
236 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 6 0.0027
237 MENINGITIS ASEPTIC 12 0.0027
238 INTERVERTEBRAL DISCITIS 5 0.0026
239 RED CELL DISTRIBUTION WIDTH INCREASED 11 0.0026
240 MARASMUS 4 0.0026
241 LUMBAR VERTEBRAL FRACTURE 12 0.0026
242 HERPES SIMPLEX 17 0.0026
243 PIGMENTATION DISORDER 16 0.0026
244 HAEMOLYSIS 20 0.0026
245 PANCYTOPENIA 144 0.0026
246 SARS-COV-2 TEST POSITIVE 34 0.0026
247 SUBDURAL HAEMORRHAGE 7 0.0026
248 OSTEOSCLEROSIS 4 0.0025
249 DRUG DELIVERY SYSTEM ISSUE 5 0.0025
250 IDIOPATHIC THROMBOCYTOPENIC PURPURA 4 0.0025
251 CEREBRAL INFARCTION 60 0.0025
252 FIBULA FRACTURE 7 0.0024
253 NEAR DEATH EXPERIENCE 8 0.0024
254 NEUTROPHIL COUNT DECREASED 98 0.0024
255 BLOOD BILIRUBIN INCREASED 64 0.0024
256 LEUKAEMIA RECURRENT 4 0.0024
257 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 12 0.0024
258 HEPATOMEGALY 23 0.0023
259 DIFFUSE LARGE B-CELL LYMPHOMA 18 0.0023
260 CHRONIC LYMPHOCYTIC LEUKAEMIA 11 0.0023
261 MENINGITIS CRYPTOCOCCAL 4 0.0023
262 PORTAL HYPERTENSION 7 0.0023
263 RETROPERITONEAL HAEMATOMA 5 0.0023
264 MITRAL VALVE DISEASE 4 0.0023
265 TRANSAMINASES INCREASED 50 0.0022
266 COMPRESSION FRACTURE 12 0.0022
267 NEPHROPATHY TOXIC 25 0.0022
268 IRON DEFICIENCY 10 0.0022
269 URINARY TRACT DISORDER 10 0.0022
270 PAPILLOEDEMA 10 0.0022
271 BACTERAEMIA 26 0.0022
272 PNEUMONIA KLEBSIELLA 4 0.0022
273 CHRONIC MYELOID LEUKAEMIA 10 0.0022
274 SYNOVIAL CYST 10 0.0022
275 HYPERTRICHOSIS 4 0.0022
276 AUTOIMMUNE DISORDER 21 0.0022
277 LUNG CONSOLIDATION 6 0.0021
278 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 117 0.0021
279 PULMONARY INFARCTION 5 0.0021
280 RESPIRATORY SYMPTOM 6 0.0021
281 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 8 0.0021
282 OCULAR ICTERUS 9 0.0021
283 ISCHAEMIC STROKE 37 0.0021
284 ENTEROCOCCAL INFECTION 10 0.0021
285 HAEMATOLOGICAL INFECTION 5 0.0020
286 CEREBRAL HAEMORRHAGE 73 0.0020
287 HYPERTRANSAMINASAEMIA 14 0.0020
288 BRAIN HERNIATION 6 0.0020
289 ATYPICAL PNEUMONIA 6 0.0020
290 SUSPECTED OFF LABEL USE 9 0.0020
291 SYSTEMIC CANDIDA 5 0.0020
292 URINARY TRACT INFECTION BACTERIAL 5 0.0020
293 EAR HAEMORRHAGE 4 0.0020
294 DEEP VEIN THROMBOSIS 128 0.0020
295 HAEMORRHAGE URINARY TRACT 5 0.0020
296 NEUTROPENIC SEPSIS 14 0.0020
297 RED BLOOD CELL COUNT DECREASED 56 0.0020
298 INTRACARDIAC THROMBUS 6 0.0020
299 HEPATOSPLENOMEGALY 5 0.0019
300 CACHEXIA 10 0.0019
301 PHYSICAL DECONDITIONING 5 0.0019
302 CAPILLARY LEAK SYNDROME 4 0.0019
303 BLOOD CREATININE DECREASED 6 0.0019
304 EYE CONTUSION 4 0.0019
305 LOW BIRTH WEIGHT BABY 15 0.0019
306 HYPOVOLAEMIC SHOCK 9 0.0019
307 ALCOHOL POISONING 5 0.0019
308 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 14 0.0019
309 PNEUMONIA BACTERIAL 17 0.0019
310 STAPHYLOCOCCAL BACTERAEMIA 8 0.0018
311 NORMAL NEWBORN 10 0.0018
312 INTERNAL HAEMORRHAGE 21 0.0018
313 ACUTE MYOCARDIAL INFARCTION 54 0.0018
314 BLOOD LACTATE DEHYDROGENASE INCREASED 29 0.0018
315 PRODUCT USE IN UNAPPROVED INDICATION 445 0.0018
316 ISCHAEMIA 8 0.0017
317 FUNGAL SKIN INFECTION 7 0.0017
318 TREATMENT FAILURE 143 0.0017
319 TONSILLITIS 9 0.0017
320 FEBRILE NEUTROPENIA 114 0.0017
321 POLYURIA 14 0.0017
322 HAEMORRHAGE SUBCUTANEOUS 6 0.0017
323 HEPATIC FUNCTION ABNORMAL 63 0.0017
324 FIBRIN D DIMER INCREASED 6 0.0017
325 BRONCHOPULMONARY ASPERGILLOSIS 13 0.0017
326 APHTHOUS ULCER 13 0.0017
327 SUBARACHNOID HAEMORRHAGE 17 0.0017
328 GINGIVITIS 9 0.0017
329 EMBOLISM VENOUS 5 0.0016
330 CARDIAC FAILURE CHRONIC 7 0.0016
331 PRODUCT PRESCRIBING ERROR 39 0.0016
332 FEAR 44 0.0016
333 WOUND HAEMORRHAGE 6 0.0016
334 COAGULOPATHY 27 0.0016
335 BRAIN DEATH 5 0.0016
336 PULMONARY ALVEOLAR HAEMORRHAGE 9 0.0016
337 BRAIN ABSCESS 4 0.0016
338 LOSS OF THERAPEUTIC RESPONSE 5 0.0016
339 HAEMATOCRIT DECREASED 31 0.0016
340 LIMB INJURY 42 0.0015
341 MUCORMYCOSIS 4 0.0015
342 RETINAL DISORDER 4 0.0015
343 SUBDURAL HAEMATOMA 22 0.0015
344 BACTERIAL SEPSIS 5 0.0015
345 DISEASE COMPLICATION 7 0.0015
346 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 4 0.0015
347 HEPATOTOXICITY 34 0.0015
348 HYPOGAMMAGLOBULINAEMIA 10 0.0015
349 DEAFNESS NEUROSENSORY 5 0.0015
350 LUNG OPACITY 4 0.0015
351 FURUNCLE 12 0.0015
352 PREMATURE DELIVERY 24 0.0015
353 POTENTIATING DRUG INTERACTION 5 0.0015
354 OVERWEIGHT 8 0.0015
355 CEREBRAL HAEMATOMA 5 0.0015
356 PULMONARY EMBOLISM 139 0.0015
357 HEPATIC FIBROSIS 5 0.0015
358 ACUTE CORONARY SYNDROME 12 0.0014
359 GUILLAIN-BARRE SYNDROME 7 0.0014
360 RASH MORBILLIFORM 4 0.0014
361 THROMBOSIS 116 0.0014
362 EPSTEIN-BARR VIRUS INFECTION 9 0.0014
363 COVID-19 PNEUMONIA 17 0.0014
364 THERAPEUTIC RESPONSE DECREASED 87 0.0014
365 CAROTID ARTERY STENOSIS 5 0.0014
366 SKIN HAEMORRHAGE 21 0.0014
367 QUALITY OF LIFE DECREASED 19 0.0014
368 ACUTE LYMPHOCYTIC LEUKAEMIA 4 0.0014
369 CHOLECYSTITIS ACUTE 8 0.0014
370 UTERINE HAEMORRHAGE 6 0.0014
371 PULMONARY HAEMORRHAGE 11 0.0014
372 HYPERNATRAEMIA 7 0.0014
373 RETINAL HAEMORRHAGE 10 0.0014
374 PRODUCT DISTRIBUTION ISSUE 13 0.0014
375 DRUG RESISTANCE 36 0.0014
376 TOXIC SKIN ERUPTION 14 0.0014
377 KLEBSIELLA INFECTION 7 0.0014
378 SEPSIS 154 0.0014
379 HAEMATOTOXICITY 13 0.0014
380 CORONAVIRUS INFECTION 9 0.0014
381 LYMPHOPENIA 19 0.0013
382 LEUKOENCEPHALOPATHY 5 0.0013
383 HEPATIC CIRRHOSIS 25 0.0013
384 LIVER DISORDER 59 0.0013
385 HEPATITIS C 16 0.0013
386 FULL BLOOD COUNT ABNORMAL 14 0.0013
387 DIABETIC FOOT 4 0.0013
388 MULTIPLE ORGAN DYSFUNCTION SYNDROME 37 0.0013
389 JOINT EFFUSION 9 0.0013
390 LIVER INJURY 32 0.0013
391 SYSTEMIC LUPUS ERYTHEMATOSUS 46 0.0013
392 MULTIPLE-DRUG RESISTANCE 4 0.0013
393 HEPATIC ENCEPHALOPATHY 12 0.0013
394 PSEUDOMONAS INFECTION 11 0.0013
395 BLOOD IRON DECREASED 15 0.0013
396 JAUNDICE 34 0.0013
397 HAEMATURIA 43 0.0013
398 GASTROINTESTINAL TOXICITY 6 0.0012
399 ACUTE PULMONARY OEDEMA 7 0.0012
400 CYSTITIS HAEMORRHAGIC 5 0.0012
401 LIVER ABSCESS 4 0.0012
402 ANTINUCLEAR ANTIBODY POSITIVE 4 0.0012
403 HEPATITIS ACUTE 8 0.0012
404 INFLUENZA 137 0.0012
405 ASPHYXIA 10 0.0012
406 ILLNESS 126 0.0012
407 ABNORMAL FAECES 10 0.0012
408 ANAPHYLACTOID REACTION 5 0.0012
409 IMMUNE SYSTEM DISORDER 16 0.0012
410 VIRAL INFECTION 40 0.0012
411 SEPTIC SHOCK 52 0.0012
412 SPINAL PAIN 14 0.0012
413 FULL BLOOD COUNT DECREASED 24 0.0012
414 PARALYSIS 17 0.0012
415 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 6 0.0012
416 MELAENA 26 0.0012
417 BACTERIAL INFECTION 22 0.0012
418 PALLOR 32 0.0012
419 NEPHROTIC SYNDROME 8 0.0012
420 ASCITES 34 0.0012
421 ANAEMIA 219 0.0011
422 PRESCRIBED OVERDOSE 22 0.0011
423 JAUNDICE CHOLESTATIC 4 0.0011
424 PULMONARY TOXICITY 8 0.0011
425 PREMATURE BABY 34 0.0011
426 BLOOD CREATINE INCREASED 5 0.0011
427 MACULOPATHY 4 0.0011
428 INFECTION 163 0.0011
429 WHITE BLOOD CELL COUNT INCREASED 43 0.0011
430 DEPRESSED MOOD 59 0.0011
431 LEUKOCYTOSIS 20 0.0011
432 SCLERODERMA 4 0.0011
433 HEPATIC CYTOLYSIS 14 0.0011
434 HEPATITIS 28 0.0011
435 ASTHENOPIA 6 0.0011
436 HEMIPLEGIA 9 0.0011
437 WHITE BLOOD CELL COUNT DECREASED 117 0.0011
438 INTRACRANIAL PRESSURE INCREASED 6 0.0011
439 HEPATIC FAILURE 32 0.0011
440 GRANULOCYTOPENIA 6 0.0011
441 HEAD INJURY 33 0.0010
442 APATHY 15 0.0010
443 MYELOSUPPRESSION 37 0.0010
444 HAEMORRHOIDAL HAEMORRHAGE 5 0.0010
445 KIDNEY INFECTION 20 0.0010
446 LYMPHOCYTE COUNT DECREASED 18 0.0010
447 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 6 0.0010
448 ALANINE AMINOTRANSFERASE INCREASED 62 0.0010
449 ORGANISING PNEUMONIA 5 0.0010
450 CHOLECYSTITIS 12 0.0010
451 ABDOMINAL TENDERNESS 5 0.0010
452 GINGIVAL PAIN 8 0.0010
453 OVARIAN CYST 10 0.0010
454 BLOOD DISORDER 8 0.0010
455 MOUTH ULCERATION 21 0.0010
456 ERYSIPELAS 5 0.0010
457 RASH MACULO-PAPULAR 22 0.0010
458 HAND FRACTURE 7 0.0010
459 INTERNATIONAL NORMALISED RATIO DECREASED 4 0.0010
460 FOETAL GROWTH RESTRICTION 6 0.0010
461 RECURRENT CANCER 4 0.0010
462 PERIPHERAL ISCHAEMIA 4 0.0010
463 PERIPHERAL VENOUS DISEASE 4 0.0010
464 BENIGN PROSTATIC HYPERPLASIA 5 0.0010
465 DRUG INTOLERANCE 93 0.0010
466 FLANK PAIN 9 0.0010
467 PYREXIA 331 0.0010
468 TACHYPNOEA 13 0.0010
469 DERMATITIS ALLERGIC 12 0.0010
470 CYANOSIS 15 0.0010
471 LABORATORY TEST ABNORMAL 28 0.0009
472 PERIPHERAL COLDNESS 13 0.0009
473 CLOSTRIDIUM DIFFICILE COLITIS 10 0.0009
474 GENERAL PHYSICAL HEALTH DETERIORATION 109 0.0009
475 ESCHERICHIA URINARY TRACT INFECTION 4 0.0009
476 RENAL IMPAIRMENT 79 0.0009
477 WHITE BLOOD CELL COUNT ABNORMAL 6 0.0009
478 ABSCESS 15 0.0009
479 POOR PERIPHERAL CIRCULATION 4 0.0009
480 INFLAMMATION 48 0.0009
481 COVID-19 163 0.0009
482 ANGINA UNSTABLE 6 0.0009
483 INTESTINAL ISCHAEMIA 5 0.0009
484 GAMMA-GLUTAMYLTRANSFERASE INCREASED 20 0.0009
485 MENINGITIS 6 0.0009
486 HYPERTHYROIDISM 13 0.0009
487 OFF LABEL USE 786 0.0009
488 CYTOKINE RELEASE SYNDROME 18 0.0009
489 HEPATIC ENZYME INCREASED 61 0.0009
490 MALNUTRITION 10 0.0009
491 GASTROINTESTINAL INFECTION 8 0.0009
492 SKIN DISCOLOURATION 41 0.0009
493 MUCOSAL INFLAMMATION 23 0.0009
494 GASTRIC HAEMORRHAGE 10 0.0009
495 HERPES VIRUS INFECTION 5 0.0009
496 DISEASE PROGRESSION 102 0.0009
497 RALES 5 0.0009
498 HEPATIC STEATOSIS 16 0.0009
499 PERFORMANCE STATUS DECREASED 4 0.0009
500 BLOOD TEST ABNORMAL 12 0.0009
501 DISSEMINATED INTRAVASCULAR COAGULATION 12 0.0009
502 DUODENAL ULCER 6 0.0008
503 LEUKAEMIA 8 0.0008
504 HEPATOCELLULAR INJURY 12 0.0008
505 SARCOIDOSIS 4 0.0008
506 PLEURISY 5 0.0008
507 CHROMATURIA 19 0.0008
508 THIRST 15 0.0008
509 LIVER FUNCTION TEST INCREASED 18 0.0008
510 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 8 0.0008
511 ODYNOPHAGIA 5 0.0008
512 GASTRITIS 22 0.0008
513 GANGRENE 5 0.0008
514 GASTROINTESTINAL HAEMORRHAGE 69 0.0008
515 EYE HAEMORRHAGE 11 0.0008
516 INCORRECT DOSAGE ADMINISTERED 4 0.0008
517 LOWER GASTROINTESTINAL HAEMORRHAGE 6 0.0008
518 ACUTE KIDNEY INJURY 124 0.0008
519 SKIN SWELLING 7 0.0008
520 IMMUNODEFICIENCY 12 0.0008
521 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 57 0.0008
522 PANCREATITIS ACUTE 18 0.0008
523 HYPERAMMONAEMIA 4 0.0008
524 PNEUMOCYSTIS JIROVECII PNEUMONIA 8 0.0008
525 JOINT INJURY 17 0.0008
526 IMMUNOSUPPRESSION 7 0.0008
527 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 7 0.0008
528 MUSCLE ATROPHY 10 0.0008
529 DIABETES MELLITUS 60 0.0008
530 TOOTH ABSCESS 8 0.0008
531 FAECES DISCOLOURED 17 0.0008
532 AMMONIA INCREASED 4 0.0008
533 FEMORAL NECK FRACTURE 4 0.0008
534 ENDOCARDITIS 4 0.0008
535 HELICOBACTER INFECTION 8 0.0008
536 LYMPHOMA 12 0.0008
537 UPPER GASTROINTESTINAL HAEMORRHAGE 13 0.0008
538 ASPARTATE AMINOTRANSFERASE INCREASED 41 0.0008
539 HYPOALBUMINAEMIA 6 0.0008
540 TENDERNESS 8 0.0008
541 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 138 0.0008
542 DRUG-INDUCED LIVER INJURY 24 0.0008
543 CIRCULATORY COLLAPSE 13 0.0008
544 ACCIDENT 9 0.0008
545 EATING DISORDER 16 0.0008
546 PNEUMONIA 243 0.0007
547 APPENDICITIS 7 0.0007
548 ANAL ABSCESS 4 0.0007
549 SPINAL DISORDER 7 0.0007
550 GENERAL PHYSICAL CONDITION ABNORMAL 5 0.0007
551 BLOOD TRIGLYCERIDES INCREASED 13 0.0007
552 LYMPHADENOPATHY 26 0.0007
553 BONE PAIN 43 0.0007
554 CHOLELITHIASIS 24 0.0007
555 HICCUPS 6 0.0007
556 RESPIRATORY TRACT INFECTION 19 0.0007
557 CHOLESTASIS 14 0.0007
558 STAPHYLOCOCCAL INFECTION 24 0.0007
559 HAEMATOCHEZIA 40 0.0007
560 MENSTRUAL DISORDER 6 0.0007
561 ENCEPHALITIS 5 0.0007
562 SECOND PRIMARY MALIGNANCY 6 0.0007
563 STREPTOCOCCAL INFECTION 4 0.0007
564 VAGINAL HAEMORRHAGE 31 0.0007
565 HAEMATEMESIS 18 0.0007
566 NEUTROPENIA 96 0.0007
567 CATARACT 42 0.0007
568 FACIAL PARALYSIS 6 0.0007
569 DEATH 606 0.0007
570 DRUG INEFFECTIVE 922 0.0007
571 SKIN HYPERPIGMENTATION 6 0.0007
572 ALTERED STATE OF CONSCIOUSNESS 15 0.0007
573 ENCEPHALOPATHY 17 0.0007
574 POST PROCEDURAL HAEMORRHAGE 8 0.0007
575 RASH MACULAR 24 0.0007
576 HYPERGLYCAEMIA 25 0.0007
577 GASTROENTERITIS 10 0.0007
578 INCORRECT DOSE ADMINISTERED 156 0.0007
579 ORAL DISORDER 5 0.0007
580 EAR DISCOMFORT 7 0.0007
581 BLOOD CREATININE INCREASED 44 0.0007
582 HYDRONEPHROSIS 5 0.0007
583 DYSPHONIA 39 0.0007
584 HYPERTENSION 141 0.0007
585 HEPATITIS B 4 0.0007
586 SUDDEN DEATH 7 0.0007
587 PNEUMONITIS 18 0.0007
588 COLITIS 25 0.0007
589 ACUTE HEPATIC FAILURE 9 0.0007
590 HYPOTHYROIDISM 21 0.0007
591 FOETAL EXPOSURE DURING PREGNANCY 53 0.0007
592 POOR QUALITY SLEEP 14 0.0006
593 IRON DEFICIENCY ANAEMIA 6 0.0006
594 DEVICE RELATED INFECTION 10 0.0006
595 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 19 0.0006
596 THROAT IRRITATION 29 0.0006
597 CHOLANGITIS 4 0.0006
598 RENAL FAILURE 85 0.0006
599 HEADACHE 401 0.0006
600 INTENTIONAL PRODUCT USE ISSUE 56 0.0006
601 DYSPHAGIA 60 0.0006
602 BLOOD URINE PRESENT 12 0.0006
603 PERITONITIS 13 0.0006
604 ILL-DEFINED DISORDER 38 0.0006
605 RHINITIS 5 0.0006
606 EYE INFECTION 7 0.0006
607 ATRIAL FIBRILLATION 60 0.0006
608 DEAFNESS 16 0.0006
609 LIGAMENT SPRAIN 6 0.0006
610 ASTHENIA 228 0.0006
611 C-REACTIVE PROTEIN INCREASED 22 0.0006
612 MALAISE 264 0.0006
613 CARDIAC FAILURE ACUTE 4 0.0006
614 PNEUMONIA ASPIRATION 15 0.0006
615 BLOOD UREA INCREASED 10 0.0006
616 COLITIS ISCHAEMIC 4 0.0006
617 PRODUCT USE ISSUE 111 0.0006
618 LIVER FUNCTION TEST ABNORMAL 17 0.0006
619 FRACTURE 11 0.0006
620 ANURIA 5 0.0006
621 PYELONEPHRITIS 5 0.0006
622 PULMONARY HYPERTENSION 12 0.0006
623 APHONIA 8 0.0006
624 MASS 8 0.0006
625 GLAUCOMA 11 0.0006
626 PHARYNGITIS 7 0.0006
627 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 114 0.0006
628 PULMONARY THROMBOSIS 6 0.0005
629 FEEDING DISORDER 11 0.0005
630 UROSEPSIS 5 0.0005
631 MATERNAL EXPOSURE DURING PREGNANCY 48 0.0005
632 DEMENTIA 15 0.0005
633 RENAL DISORDER 25 0.0005
634 CARDIAC FAILURE 43 0.0005
635 PHOTOPHOBIA 10 0.0005
636 SYNCOPE 53 0.0005
637 GASTRIC ULCER 10 0.0005
638 HAEMODYNAMIC INSTABILITY 4 0.0005
639 BLOOD ALKALINE PHOSPHATASE INCREASED 13 0.0005
640 ACIDOSIS 4 0.0005
641 NEOPLASM 6 0.0005
642 SHOCK 12 0.0005
643 ACUTE RESPIRATORY FAILURE 10 0.0005
644 MUSCULOSKELETAL CHEST PAIN 8 0.0005
645 CELLULITIS 26 0.0005
646 CHOKING 10 0.0005
647 RECTAL HAEMORRHAGE 22 0.0005
648 COELIAC DISEASE 5 0.0005
649 CENTRAL NERVOUS SYSTEM LESION 7 0.0005
650 PLEURAL EFFUSION 31 0.0005
651 ARTERIAL OCCLUSIVE DISEASE 4 0.0005
652 THERAPY CHANGE 5 0.0005
653 DIVERTICULITIS 14 0.0005
654 URINARY TRACT INFECTION 86 0.0005
655 BLOOD PRESSURE ABNORMAL 10 0.0005
656 HUNGER 7 0.0005
657 HAEMOPTYSIS 14 0.0005
658 BLINDNESS UNILATERAL 7 0.0005
659 LOCALISED INFECTION 12 0.0005
660 RESPIRATORY FAILURE 36 0.0005
661 DRUG INTERACTION 78 0.0005
662 DECREASED APPETITE 114 0.0005
663 CONDITION AGGRAVATED 149 0.0005
664 NEUTROPHIL COUNT INCREASED 5 0.0005
665 OSTEOPOROSIS 20 0.0005
666 GENERALISED OEDEMA 6 0.0005
667 CYST 6 0.0005
668 BLISTER 27 0.0005
669 FATIGUE 374 0.0005
670 FACE OEDEMA 8 0.0005
671 SKIN LESION 13 0.0005
672 FEELING ABNORMAL 113 0.0005
673 PULMONARY MASS 7 0.0005
674 APHASIA 14 0.0005
675 OESOPHAGITIS 5 0.0005
676 BLOOD CALCIUM INCREASED 4 0.0005
677 ACUTE RESPIRATORY DISTRESS SYNDROME 8 0.0005
678 BACK PAIN 105 0.0005
679 VISUAL IMPAIRMENT 56 0.0005
680 PAIN IN EXTREMITY 133 0.0005
681 BLOOD CHOLESTEROL INCREASED 21 0.0005
682 VENTRICULAR FIBRILLATION 5 0.0004
683 ABDOMINAL DISCOMFORT 75 0.0004
684 GOUT 8 0.0004
685 ANAL INCONTINENCE 4 0.0004
686 BLOOD CALCIUM DECREASED 5 0.0004
687 WEIGHT DECREASED 124 0.0004
688 OROPHARYNGEAL PAIN 41 0.0004
689 OROPHARYNGEAL DISCOMFORT 4 0.0004
690 ABDOMINAL PAIN 103 0.0004
691 REBOUND EFFECT 5 0.0004
692 TOOTHACHE 8 0.0004
693 BLINDNESS 18 0.0004
694 CRYING 16 0.0004
695 MYOCARDIAL ISCHAEMIA 5 0.0004
696 SWELLING 41 0.0004
697 MYALGIA 74 0.0004
698 HERPES ZOSTER 25 0.0004
699 NERVE COMPRESSION 4 0.0004
700 PERICARDIAL EFFUSION 10 0.0004
701 LACTIC ACIDOSIS 14 0.0004
702 CARDIO-RESPIRATORY ARREST 18 0.0004
703 AGRANULOCYTOSIS 8 0.0004
704 SWELLING FACE 28 0.0004
705 WOUND 12 0.0004
706 VASCULITIS 5 0.0004
707 EYE DISORDER 14 0.0004
708 PULMONARY OEDEMA 19 0.0004
709 OEDEMA 23 0.0004
710 DIPLOPIA 11 0.0004
711 DRUG LEVEL INCREASED 7 0.0004
712 PROTEINURIA 8 0.0004
713 LEUKOPENIA 21 0.0004
714 COUGH 117 0.0004
715 WRIST FRACTURE 5 0.0004
716 PERICARDITIS 7 0.0004
717 NERVOUS SYSTEM DISORDER 13 0.0004
718 PERIPHERAL SWELLING 64 0.0004
719 DIARRHOEA 268 0.0004
720 CANDIDA INFECTION 7 0.0004
721 PULMONARY ARTERIAL HYPERTENSION 6 0.0004
722 HYPOKINESIA 6 0.0004
723 HEMIPARESIS 7 0.0004
724 PRODUCT PRESCRIBING ISSUE 9 0.0004
725 ABDOMINAL PAIN UPPER 85 0.0004
726 HAEMORRHOIDS 8 0.0004
727 NO THERAPEUTIC RESPONSE 5 0.0004
728 LUNG DISORDER 20 0.0004
729 MENORRHAGIA 8 0.0004
730 MUSCULOSKELETAL DISCOMFORT 7 0.0004
731 MUSCULAR WEAKNESS 46 0.0004
732 PRODUCT DOSE OMISSION ISSUE 119 0.0004
733 COLON CANCER 6 0.0004
734 ILEUS 5 0.0004
735 DYSARTHRIA 15 0.0004
736 BRAIN OEDEMA 5 0.0004
737 STOMATITIS 24 0.0004
738 HEAD DISCOMFORT 7 0.0004
739 DRY MOUTH 32 0.0004
740 CHEST PAIN 73 0.0004
741 EPILEPSY 12 0.0004
742 GASTROINTESTINAL DISORDER 35 0.0004
743 HYPOKALAEMIA 18 0.0004
744 NEOPLASM MALIGNANT 26 0.0004
745 LIMB DISCOMFORT 12 0.0004
746 MIGRAINE 37 0.0004
747 ARTHRALGIA 161 0.0004
748 OSTEOMYELITIS 7 0.0004
749 LUNG INFECTION 6 0.0004
750 TRANSIENT ISCHAEMIC ATTACK 13 0.0004
751 ANGINA PECTORIS 11 0.0004
752 NODULE 5 0.0004
753 PANCREATITIS 20 0.0004
754 CONJUNCTIVITIS 7 0.0004
755 VOMITING 177 0.0004
756 EAR INFECTION 10 0.0004
757 BREAST PAIN 4 0.0004
758 BODY HEIGHT DECREASED 4 0.0004
759 MOVEMENT DISORDER 12 0.0004
760 MYOCARDIAL INFARCTION 65 0.0004
761 CEREBROVASCULAR ACCIDENT 63 0.0004
762 INTERSTITIAL LUNG DISEASE 18 0.0004
763 FIBROMYALGIA 9 0.0004
764 HYPOCALCAEMIA 7 0.0004
765 MOOD ALTERED 10 0.0004
766 NERVOUSNESS 19 0.0004
767 OBSTRUCTIVE AIRWAYS DISORDER 4 0.0004
768 GAIT INABILITY 12 0.0004
769 ORAL HERPES 7 0.0004
770 THERAPEUTIC PRODUCT EFFECT DECREASED 16 0.0004
771 SKIN INFECTION 4 0.0004
772 OXYGEN SATURATION DECREASED 20 0.0004
773 DYSPEPSIA 35 0.0004
774 PRODUCT DOSE OMISSION IN ERROR 10 0.0004
775 HYPOGLYCAEMIA 17 0.0004
776 PRODUCT ADMINISTRATION ERROR 7 0.0003
777 ANOSMIA 5 0.0003
778 MENTAL DISORDER 15 0.0003
779 SPEECH DISORDER 18 0.0003
780 DIZZINESS 171 0.0003
781 CARDIAC ARREST 28 0.0003
782 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
783 RENAL INJURY 10 0.0003
784 GALLBLADDER DISORDER 6 0.0003
785 ABDOMINAL DISTENSION 35 0.0003
786 RESPIRATORY DISORDER 10 0.0003
787 PELVIC PAIN 6 0.0003
788 BURSITIS 4 0.0003
789 FALL 109 0.0003
790 TYPE 2 DIABETES MELLITUS 11 0.0003
791 RESPIRATORY ARREST 9 0.0003
792 BLOOD GLUCOSE ABNORMAL 6 0.0003
793 BASAL CELL CARCINOMA 5 0.0003
794 INTERVERTEBRAL DISC PROTRUSION 7 0.0003
795 OEDEMA PERIPHERAL 39 0.0003
796 ARTHRITIS 25 0.0003
797 PNEUMOTHORAX 5 0.0003
798 NASOPHARYNGITIS 58 0.0003
799 FLUID RETENTION 16 0.0003
800 INCREASED APPETITE 6 0.0003
801 OBESITY 5 0.0003
802 SLEEP DISORDER 22 0.0003
803 DISCOMFORT 19 0.0003
804 HERNIA 6 0.0003
805 CHILLS 36 0.0003
806 VISION BLURRED 42 0.0003
807 OSTEONECROSIS 10 0.0003
808 ORAL CANDIDIASIS 4 0.0003
809 GAIT DISTURBANCE 58 0.0003
810 SEIZURE 35 0.0003
811 ADVERSE DRUG REACTION 27 0.0003
812 FUNGAL INFECTION 10 0.0003
813 SKIN DISORDER 10 0.0003
814 FLATULENCE 17 0.0003
815 LOSS OF CONSCIOUSNESS 38 0.0003
816 HYPOMAGNESAEMIA 4 0.0003
817 EOSINOPHILIA 5 0.0003
818 TOXICITY TO VARIOUS AGENTS 48 0.0003
819 METASTASES TO LIVER 5 0.0003
820 NEPHROLITHIASIS 13 0.0003
821 MALIGNANT NEOPLASM PROGRESSION 29 0.0003
822 DRUG ERUPTION 5 0.0003
823 PLASMA CELL MYELOMA 11 0.0003
824 NAUSEA 223 0.0003
825 TACHYCARDIA 25 0.0003
826 UPPER RESPIRATORY TRACT INFECTION 13 0.0003
827 ANXIETY 80 0.0003
828 AGEUSIA 7 0.0003
829 CONFUSIONAL STATE 45 0.0003
830 DEHYDRATION 37 0.0003
831 CARDIOVASCULAR DISORDER 7 0.0003
832 EXPOSURE DURING PREGNANCY 17 0.0003
833 DYSURIA 10 0.0003
834 VISUAL ACUITY REDUCED 9 0.0003
835 BLOOD PRESSURE DECREASED 18 0.0003
836 MEMORY IMPAIRMENT 37 0.0003
837 NECK PAIN 15 0.0003
838 BLOOD PRESSURE INCREASED 41 0.0003
839 ORAL PAIN 6 0.0003
840 MOBILITY DECREASED 19 0.0003
841 ACNE 20 0.0003
842 RHINORRHOEA 17 0.0003
843 ALOPECIA 51 0.0003
844 OSTEOARTHRITIS 11 0.0003
845 DELIRIUM 9 0.0003
846 BURNING SENSATION 18 0.0003
847 HEART RATE DECREASED 9 0.0003
848 PAIN 155 0.0003
849 BODY TEMPERATURE INCREASED 5 0.0002
850 URTICARIA 41 0.0002
851 PRURITUS 93 0.0002
852 DISTURBANCE IN ATTENTION 13 0.0002
853 HOSPITALISATION 37 0.0002
854 HYPOAESTHESIA 36 0.0002
855 DYSSTASIA 7 0.0002
856 ADVERSE EVENT 22 0.0002
857 DERMATITIS 5 0.0002
858 SINUSITIS 24 0.0002
859 IRRITABILITY 14 0.0002
860 BLOOD POTASSIUM DECREASED 7 0.0002
861 RASH 101 0.0002
862 DYSPNOEA 131 0.0002
863 PRODUCT DISPENSING ERROR 5 0.0002
864 ECZEMA 12 0.0002
865 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
866 DISORIENTATION 9 0.0002
867 CHRONIC KIDNEY DISEASE 17 0.0002
868 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
869 FREQUENT BOWEL MOVEMENTS 6 0.0002
870 GASTROENTERITIS VIRAL 4 0.0002
871 NASAL CONGESTION 13 0.0002
872 DRY EYE 11 0.0002
873 CONSTIPATION 48 0.0002
874 LOWER RESPIRATORY TRACT INFECTION 10 0.0002
875 MOOD SWINGS 7 0.0002
876 METABOLIC ACIDOSIS 7 0.0002
877 INSOMNIA 58 0.0002
878 HIP FRACTURE 7 0.0002
879 BLOOD GLUCOSE INCREASED 41 0.0002
880 INTENTIONAL PRODUCT MISUSE 19 0.0002
881 TREMOR 36 0.0002
882 WEIGHT INCREASED 48 0.0002
883 BLOOD SODIUM DECREASED 4 0.0002
884 ARRHYTHMIA 10 0.0002
885 LIP SWELLING 7 0.0002
886 PARAESTHESIA 33 0.0002
887 PRODUCTIVE COUGH 10 0.0002
888 RASH ERYTHEMATOUS 10 0.0002
889 HYPOACUSIS 9 0.0002
890 BLOOD GLUCOSE DECREASED 10 0.0002
891 HEPATIC CANCER 5 0.0002
892 SOMNOLENCE 41 0.0002
893 URINARY INCONTINENCE 6 0.0002
894 AMNESIA 13 0.0002
895 ABORTION SPONTANEOUS 8 0.0002
896 JOINT SWELLING 24 0.0002
897 GLYCOSYLATED HAEMOGLOBIN INCREASED 5 0.0002
898 GASTRIC CANCER 5 0.0002
899 VERTIGO 12 0.0002
900 EYE PAIN 11 0.0002
901 HYPERHIDROSIS 25 0.0002
902 RESTLESSNESS 7 0.0002
903 HALLUCINATION, VISUAL 4 0.0002
904 BRONCHITIS 14 0.0002
905 HYPERSENSITIVITY 35 0.0002
906 INJURY 13 0.0002
907 RESPIRATORY DISTRESS 5 0.0002
908 MENTAL STATUS CHANGES 5 0.0002
909 STEVENS-JOHNSON SYNDROME 4 0.0002
910 MEDICATION ERROR 10 0.0002
911 DRY SKIN 24 0.0002
912 HYPOTENSION 36 0.0002
913 FEELING HOT 11 0.0002
914 HYPONATRAEMIA 10 0.0002
915 ERYTHEMA 36 0.0002
916 HEART RATE INCREASED 17 0.0002
917 CARDIAC DISORDER 16 0.0002
918 INFLUENZA LIKE ILLNESS 14 0.0002
919 COMA 8 0.0002
920 RHABDOMYOLYSIS 7 0.0002
921 DEPRESSION 38 0.0002
922 BLOOD PRESSURE FLUCTUATION 4 0.0002
923 INFUSION RELATED REACTION 11 0.0002
924 NEURALGIA 4 0.0002
925 TREATMENT NONCOMPLIANCE 9 0.0002
926 MUSCULOSKELETAL STIFFNESS 14 0.0002
927 ABDOMINAL PAIN LOWER 4 0.0002
928 CYSTITIS 5 0.0002
929 CHEST DISCOMFORT 16 0.0002
930 NIGHT SWEATS 5 0.0002
931 SKIN ULCER 4 0.0002
932 JOINT STIFFNESS 4 0.0002
933 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
934 COGNITIVE DISORDER 7 0.0001
935 PAIN OF SKIN 4 0.0001
936 NEUROPATHY PERIPHERAL 14 0.0001
937 LUNG NEOPLASM MALIGNANT 6 0.0001
938 ANAPHYLACTIC REACTION 8 0.0001
939 OVERDOSE 31 0.0001
940 FEELING COLD 4 0.0001
941 HYPERKALAEMIA 5 0.0001
942 PAIN IN JAW 4 0.0001
943 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
944 BALANCE DISORDER 12 0.0001
945 PANCREATIC CARCINOMA 4 0.0001
946 NO ADVERSE EVENT 25 0.0001
947 GASTROOESOPHAGEAL REFLUX DISEASE 11 0.0001
948 PALPITATIONS 16 0.0001
949 PSYCHOTIC DISORDER 4 0.0001
950 COLITIS ULCERATIVE 6 0.0001
951 DYSPNOEA EXERTIONAL 5 0.0001
952 INTESTINAL OBSTRUCTION 5 0.0001
953 CORONARY ARTERY DISEASE 4 0.0001
954 OCULAR HYPERAEMIA 6 0.0001
955 AGITATION 9 0.0001
956 LETHARGY 7 0.0001
957 MUSCLE SPASMS 22 0.0001
958 HALLUCINATION 9 0.0001
959 HOT FLUSH 9 0.0001
960 EYE PRURITUS 4 0.0001
961 BLADDER CANCER 7 0.0001
962 WHEEZING 7 0.0001
963 RENAL FAILURE ACUTE 5 0.0001
964 GASTRIC DISORDER 4 0.0001
965 NEOPLASM PROGRESSION 4 0.0001
966 HYPOXIA 4 0.0001
967 BRADYCARDIA 6 0.0001
968 DRUG DEPENDENCE 18 0.0001
969 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
970 BREAST CANCER 10 0.0001
971 SKIN EXFOLIATION 9 0.0001
972 UNEVALUABLE EVENT 8 0.0001
973 DYSKINESIA 4 0.0001
974 THERAPY CESSATION 5 0.0001
975 ROAD TRAFFIC ACCIDENT 4 0.0001
976 MUSCULOSKELETAL PAIN 5 0.0001
977 DYSGEUSIA 7 0.0001
978 THERAPY INTERRUPTED 6 0.0001
979 AGGRESSION 4 0.0001
980 DERMATITIS ATOPIC 4 0.0001
981 RASH PRURITIC 4 0.0001
982 EYE IRRITATION 4 0.0001
983 PRODUCT SUBSTITUTION ISSUE 4 0.0001
984 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
985 EMOTIONAL DISTRESS 6 0.0000
986 PSORIASIS 6 0.0000
987 ASTHMA 4 0.0000